Lista de obras -

A fusion protein between streptavidin and the endogenous TLR4 ligand EDA targets biotinylated antigens to dendritic cells and induces T cell responses in vivo.

scientific article published on 05 September 2013

A novel dendritic cell subset involved in tumor immunosurveillance

artículo científico publicado en 2006

A peptide inhibitor of FOXP3 impairs regulatory T cell activity and improves vaccine efficacy in mice.

artículo científico publicado en 2010

A recombinant adenovirus encoding hepatitis C virus core and E1 proteins protects mice against cytokine-induced liver damage

artículo científico publicado en 2003

Abnormal priming of CD4(+) T cells by dendritic cells expressing hepatitis C virus core and E1 proteins.

artículo científico publicado en 2002

Apoptosis regulation in tetraploid cancer cells

artículo científico publicado en 2006

Bivalent therapeutic vaccine against HPV16/18 genotypes consisting of a fusion protein between the extra domain A from human fibronectin and HPV16/18 E7 viral antigens

scientific article published on 01 June 2020

CD4+/CD25+ regulatory cells inhibit activation of tumor-primed CD4+ T cells with IFN-gamma-dependent antiangiogenic activity, as well as long-lasting tumor immunity elicited by peptide vaccination.

artículo científico publicado en 2003

Calreticulin exposure dictates the immunogenicity of cancer cell death

artículo científico publicado en 2007

Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death

artículo científico publicado en 2005

Combination of a TLR4 ligand and anaphylatoxin C5a for the induction of antigen-specific cytotoxic T cell responses

artículo científico publicado en 2012

Contribution of IL-17-producing gamma delta T cells to the efficacy of anticancer chemotherapy

artículo científico publicado en 2011

Contribution of IL-17–producing γδ T cells to the efficacy of anticancer chemotherapy

Engineering Th determinants for efficient priming of humoral and cytotoxic T cell responses

artículo científico publicado en 2003

Enhancing immunogenicity of a CTL epitope from carcinoembryonic antigen by selective amino acid replacements.

artículo científico publicado en 2002

Eradication of large tumors expressing human papillomavirus E7 protein by therapeutic vaccination with E7 fused to the extra domain a from fibronectin

artículo científico publicado en 2011

Expansion of Tumor-Infiltrating CD8+ T cells Expressing PD-1 Improves the Efficacy of Adoptive T-cell Therapy.

artículo científico publicado en 2017

Hepatitis C virus induces the expression of CCL17 and CCL22 chemokines that attract regulatory T cells to the site of infection.

artículo científico publicado en 2010

Immune response against dying tumor cells

artículo científico publicado en 2004

Immunization against hepatitis C virus with a fusion protein containing the extra domain A from fibronectin and the hepatitis C virus NS3 protein

artículo científico publicado en 2009

Immunomodulatory Properties of Carvone Inhalation and Its Effects on Contextual Fear Memory in Mice.

artículo científico publicado en 2018

In vitro and in vivo down-regulation of regulatory T cell activity with a peptide inhibitor of TGF-beta1.

artículo científico publicado en 2008

In vivo depletion of T lymphocyte-specific transcription factors by RNA interference.

artículo científico publicado en 2010

Inhibition of FOXP3/NFAT Interaction Enhances T Cell Function after TCR Stimulation.

artículo científico publicado en 2015

PD-1/PD-L1 immune checkpoint and p53 loss facilitate tumor progression in activated B-cell diffuse large B-cell lymphomas

scientific article published on 11 April 2019

Peptide inhibitors of transforming growth factor-beta enhance the efficacy of antitumor immunotherapy.

artículo científico publicado en 2009

The Toll like receptor 4 ligand cold-inducible RNA-binding protein as vaccination platform against cancer

artículo científico publicado en 2017

The extra domain A from fibronectin targets antigens to TLR4-expressing cells and induces cytotoxic T cell responses in vivo

artículo científico publicado en 2007

Tumor therapy in mice by using a tumor antigen linked to modulin peptides from Staphylococcus epidermidis

artículo científico publicado en 2010

Upregulation of indoleamine 2,3-dioxygenase in hepatitis C virus infection

artículo científico publicado en 2007

Vaccination with an adenoviral vector encoding hepatitis C virus (HCV) NS3 protein protects against infection with HCV-recombinant vaccinia virus

artículo científico publicado en 2002

Lista de obras de

A fusion protein between streptavidin and the endogenous TLR4 ligand EDA targets biotinylated antigens to dendritic cells and induces T cell responses in vivo.

A novel dendritic cell subset involved in tumor immunosurveillance

A peptide inhibitor of FOXP3 impairs regulatory T cell activity and improves vaccine efficacy in mice.

A recombinant adenovirus encoding hepatitis C virus core and E1 proteins protects mice against cytokine-induced liver damage

Abnormal priming of CD4(+) T cells by dendritic cells expressing hepatitis C virus core and E1 proteins.

Apoptosis regulation in tetraploid cancer cells

Bivalent therapeutic vaccine against HPV16/18 genotypes consisting of a fusion protein between the extra domain A from human fibronectin and HPV16/18 E7 viral antigens

CD4+/CD25+ regulatory cells inhibit activation of tumor-primed CD4+ T cells with IFN-gamma-dependent antiangiogenic activity, as well as long-lasting tumor immunity elicited by peptide vaccination.

Calreticulin exposure dictates the immunogenicity of cancer cell death

Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death

Combination of a TLR4 ligand and anaphylatoxin C5a for the induction of antigen-specific cytotoxic T cell responses

Contribution of IL-17-producing gamma delta T cells to the efficacy of anticancer chemotherapy

Contribution of IL-17–producing γδ T cells to the efficacy of anticancer chemotherapy

Engineering Th determinants for efficient priming of humoral and cytotoxic T cell responses

Enhancing immunogenicity of a CTL epitope from carcinoembryonic antigen by selective amino acid replacements.

Eradication of large tumors expressing human papillomavirus E7 protein by therapeutic vaccination with E7 fused to the extra domain a from fibronectin

Expansion of Tumor-Infiltrating CD8+ T cells Expressing PD-1 Improves the Efficacy of Adoptive T-cell Therapy.

Hepatitis C virus induces the expression of CCL17 and CCL22 chemokines that attract regulatory T cells to the site of infection.

Immune response against dying tumor cells

Immunization against hepatitis C virus with a fusion protein containing the extra domain A from fibronectin and the hepatitis C virus NS3 protein

Immunomodulatory Properties of Carvone Inhalation and Its Effects on Contextual Fear Memory in Mice.

In vitro and in vivo down-regulation of regulatory T cell activity with a peptide inhibitor of TGF-beta1.

In vivo depletion of T lymphocyte-specific transcription factors by RNA interference.

Inhibition of FOXP3/NFAT Interaction Enhances T Cell Function after TCR Stimulation.

PD-1/PD-L1 immune checkpoint and p53 loss facilitate tumor progression in activated B-cell diffuse large B-cell lymphomas

Peptide inhibitors of transforming growth factor-beta enhance the efficacy of antitumor immunotherapy.

The Toll like receptor 4 ligand cold-inducible RNA-binding protein as vaccination platform against cancer

The extra domain A from fibronectin targets antigens to TLR4-expressing cells and induces cytotoxic T cell responses in vivo

Tumor therapy in mice by using a tumor antigen linked to modulin peptides from Staphylococcus epidermidis

Upregulation of indoleamine 2,3-dioxygenase in hepatitis C virus infection

Vaccination with an adenoviral vector encoding hepatitis C virus (HCV) NS3 protein protects against infection with HCV-recombinant vaccinia virus